Does POMALIDOMIDE Cause Product dose omission issue? 1,961 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,961 reports of Product dose omission issue have been filed in association with POMALIDOMIDE (Pomalyst). This represents 2.1% of all adverse event reports for POMALIDOMIDE.
1,961
Reports of Product dose omission issue with POMALIDOMIDE
2.1%
of all POMALIDOMIDE reports
7
Deaths
174
Hospitalizations
How Dangerous Is Product dose omission issue From POMALIDOMIDE?
Of the 1,961 reports, 7 (0.4%) resulted in death, 174 (8.9%) required hospitalization, and 5 (0.3%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 1,961 reports have been filed with the FAERS database.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which POMALIDOMIDE Alternatives Have Lower Product dose omission issue Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA